These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 15859928)

  • 21. Evaluation of three polymerase chain reaction tests targeting morphological transforming region II, UL-83 gene and glycoprotein O gene for the detection of human cytomegalovirus genome in clinical specimens of immunocompromised patients in Chennai, India.
    Sowmya P; Madhavan HN; Therese KL
    Virol J; 2006 Mar; 3():20. PubMed ID: 16571138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human herpesvirus 6 is an important pathogen in infectious lung disease after allogeneic bone marrow transplantation.
    Buchbinder S; Elmaagacli AH; Schaefer UW; Roggendorf M
    Bone Marrow Transplant; 2000 Sep; 26(6):639-44. PubMed ID: 11035370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preliminary report for the application of nucleic acid sequence-based amplification in detection of human cytomegalovirus (HCMV) late pp67 mRNA for diagnosis of HCMV infection.
    Pairoj W; Srichunrusami C; Chantratita W; Bodhiphala P; Sungkanuparph S; Vibhagool A
    J Med Assoc Thai; 2000 Mar; 83 Suppl 1():S28-34. PubMed ID: 10865403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis and monitoring of human cytomegalovirus diseases in patients with human immunodeficiency virus infection by use of a real-time PCR assay.
    Yoshida A; Hitomi S; Fukui T; Endo H; Morisawa Y; Kazuyama Y; Osumi K; Oka S; Kimura S
    Clin Infect Dis; 2001 Nov; 33(10):1756-61. PubMed ID: 11641826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PCR detection of viral DNA in serum as an ancillary analysis for the diagnosis of acute mononucleosis-like syndrome due to human cytomegalovirus (HCMV) in immunocompetent patients.
    Navalpotro D; Gimeno C; Navarro D
    J Clin Virol; 2006 Feb; 35(2):193-6. PubMed ID: 16125456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiplex polymerase chain reaction for the evaluation of cytomegalovirus DNA load in organ transplant recipients.
    Nazzari C; Gaeta A; Lazzarini M; Castelli TD; Mancini C
    J Med Virol; 2000 Jun; 61(2):251-8. PubMed ID: 10797382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Follow-up of 28 HCMV seropositive renal-transplant recipients: comparison of clinical, biological and virological parameters in the groups of treated versus untreated infected patients.
    Kamar N; Mengelle C; Yahyaoui S; Sandres-Sauné K; Durand D; Izopet J; Rostaing L
    J Clin Virol; 2005 May; 33(1):35-42. PubMed ID: 15797363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Detection of human cytomegalovirus infection by FQ-PCR technique and its application in the diagnosis and treatment of HCMV infected children].
    Chen F; He Z; Pan S; Ning F; Wang Q; Xiao Z
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Jun; 16(2):187-90. PubMed ID: 12196838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Longitudinal monitoring of latent and active human cytomegalovirus infections in peripheral blood of heart transplant recipients by single-tube nested RT-PCR.
    Wolff D; Skourtopoulos M; Hörnschemeyer D; Wolff C; Körner M; Körfer R; Kleesiek K
    Microbiol Res; 1996 Dec; 151(4):343-9. PubMed ID: 9022299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Whole blood real-time quantitative PCR for cytomegalovirus infection follow-up in transplant recipients.
    Garrigue I; Boucher S; Couzi L; Caumont A; Dromer C; Neau-Cransac M; Tabrizi R; Schrive MH; Fleury H; Lafon ME
    J Clin Virol; 2006 May; 36(1):72-5. PubMed ID: 16481215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monitoring of human cytomegalovirus infection in immunosuppressed patients using real-time PCR on whole blood.
    Deback C; Fillet AM; Dhedin N; Barrou B; Varnous S; Najioullah F; Bricaire F; Agut H
    J Clin Virol; 2007 Nov; 40(3):173-9. PubMed ID: 17904901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinically-based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic stem cell transplant recipients.
    Lilleri D; Baldanti F; Gatti M; Rovida F; Dossena L; De Grazia S; Torsellini M; Gerna G
    J Med Virol; 2004 Jul; 73(3):412-8. PubMed ID: 15170637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monitoring low cytomegalovirus viremia in transplanted patients by a real-time PCR on plasma.
    Schvoerer E; Henriot S; Zachary P; Freitag R; Fuchs A; Fritsch S; Risch S; Meyer N; Caillard S; Lioure B; Stoll-Keller F
    J Med Virol; 2005 May; 76(1):76-81. PubMed ID: 15778970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monitoring HCMV infection with quantitative real-time PCR in HCMV-positive orthotopic liver transplant recipients, and predictive factors for treatment of the first episode of HCMV viremia.
    Pillet A; Mengelle C; Basse G; Ribes D; Kamar N; Muscari F; Lavayssière L; Suc B; Esposito L; Peron JM; Rostaing L
    Transplant Proc; 2006 Sep; 38(7):2335-8. PubMed ID: 16980083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitation of human cytomegalovirus in recipients of solid organ transplants by real-time quantitative PCR and pp65 antigenemia.
    Mengelle C; Pasquier C; Rostaing L; Sandres-Sauné K; Puel J; Berges L; Righi L; Bouquies C; Izopet J
    J Med Virol; 2003 Feb; 69(2):225-31. PubMed ID: 12683412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of a quantitative PCR assay for CMV infection in liver transplant recipients: an intent to find the optimal cut-off value.
    Martín-Dávila P; Fortún J; Gutiérrez C; Martí-Belda P; Candelas A; Honrubia A; Barcena R; Martínez A; Puente A; de Vicente E; Moreno S
    J Clin Virol; 2005 Jun; 33(2):138-44. PubMed ID: 15911429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of antigenemia assay and semiquantitative polymerase chain reaction test for monitoring active cytomegalovirus infection in allogeneic hematopoietic cell transplant recipients.
    Pajand O; Ziyaeyan M; Mousavi S; Fatolahzadeh B; Hojabri Z; Bahador A; Abdossamadi Z
    Exp Clin Transplant; 2008 Jun; 6(2):149-54. PubMed ID: 18816243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Demonstration of cytomegalovirus after bone marrow transplantation by polymerase chain reaction, virus culture and antigen detection in buffy coat leukocytes.
    Schmidt CA; Oettle H; Wilborn F; Jessen J; Timm H; Schwerdtfeger R; Oertel J; Siegert W
    Bone Marrow Transplant; 1994 Jan; 13(1):71-5. PubMed ID: 8019456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between IgM antibody to human cytomegalovirus, virus load, donor and recipient serostatus, and administration of methylprednisolone as risk factors for cytomegalovirus disease after liver transplantation.
    Emery VC; Cope AV; Sabin CA; Burroughs AK; Rolles K; Lazzarotto T; Landini MP; Brojanac S; Wise J; Maine GT
    J Infect Dis; 2000 Dec; 182(6):1610-5. PubMed ID: 11069231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness of interleukin-10 detection in lung transplant patients with human cytomegalovirus infection with respect to virus persistence.
    Zedtwitz-Liebenstein K; Jaksch P; Wulkersdorfer B; Friehs H; Pempelfort SD; Burgmann H; Frass M
    Transplantation; 2007 Jul; 84(2):268-71. PubMed ID: 17667821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.